US CMS Providing Medicaid Coverage For COVID-19 Tests, But Congressman Still Sees Gaps For Testing Working Poor
The US Centers for Medicare and Medicaid Services (CMS) created a new billing code to help diagnose coronavirus in its beneficiaries on 5 March, as well as fact sheets on medical care and transport of COVID-19 patients, but patients who get their health care through low-cost insurance plans may not be able to afford the testing, said a House Committee chairman.
You may also be interested in...
Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.
Mayo Clinic is developing a test to detect COVID-19 in the US.
NeuMoDx Molecular announced plans to develop a coronavirus test for its own high-throughput molecular diagnostics platform.